Evaluation of Antimicrobial Activities against Various E. coli Strains of a Novel Hybrid Peptide—LENART01.

Serafin, Pawel; Kowalczyk, Paweł; Mollica, Adriano; Stefanucci, Azzurra; Laskowska, Anna K.; Zawadzka, Magdalena; Kramkowski, Karol; Kleczkowska, Patrycja

Finding the ideal antimicrobial drug with improved efficacy and a safety profile that eliminates antibiotic resistance caused by pathogens remains a difficult task. Indeed, there is an urgent need for innovation in the design and development of a microbial inhibitor. Given that many promising antimicrobial peptides with excellent broad-spectrum antibacterial properties are secreted by some frog species (e.g., bombesins, opioids, temporins, etc.), our goal was to identify the antimicrobial properties of amphibian-derived dermorphin and ranatensin peptides, which were combined to produce a hybrid compound. This new chimera (named LENART01) was tested for its antimicrobial activity against E. coli strains K12 and R1–R4, which are characterized by differences in lipopolysaccharide (LPS) core oligosaccharide structure. The results showed that LENART01 had superior activity against the R2 and R4 strains compared with the effects of the clinically available antibiotics ciprofloxacin or bleomycin (MIC values). Importantly, the inhibitory effect was not concentration dependent; however, LENART01 showed a time- and dose-dependent hemolytic effect in hemolytic assays.

ESCHERICHIA coli; PEPTIDES; ANTI-infective agents; ANTIMICROBIAL peptides; DRUG efficacy; PEPTIDE antibiotics; CATHELICIDINS

Molecules, 2023, Vol 28, Issue 13, p4955

1420-3049

Academic Journal

10.3390/molecules28134955